Julie Donovan

Julie Donovan has a diverse work experience in the field of clinical operations, with roles ranging from management positions to consulting. Julie is currently employed as a Senior Director of Clinical Operations at SwanBio Therapeutics since May 2023. Prior to this, from December 2022 to May 2023, they worked as a Clinical Operations Consultant while being self-employed. Before that, Julie served as the Senior Director of Clinical Operations at Dyne Therapeutics from August 2021 to June 2022. Julie has also held positions at Sage Therapeutics, where they served as the Director of Clinical Operations and Development from November 2018 to July 2021, and as the Associate Director of Clinical Operations and Development from September 2015 to November 2018. Julie also worked at Alnylam Pharmaceuticals as the Manager of Clinical Operations from June 2014 to July 2015. In earlier roles, Julie held various positions at Cubist Pharmaceuticals, including Senior Clinical Trials Manager, Clinical Trials Manager, Lead CRA, and In-House CRA, from September 2005 to June 2014. Julie began their career as a Clinical Trials Coordinator at Therion Biologics from 2002 to 2005, and as a Research Associate at Organogenesis from 2000 to 2002.

Julie Donovan attended Saint Anselm College, where they pursued a field of study in Biology, General. After their time at Saint Anselm College, they continued their education at the MGH Institute of Health Professions, focusing on Clinical Investigation.